Xiaoxiao Pan
FDA investigator
Appears on 1 document from 2023, mostly at sites in North Carolina. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 3.0
- Observations per 483
- 2023
- First seen
- 2023
- Most recent
What they cite most
From 3 observations- 21 CFR 211.160General requirements1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 600.14Reporting of biological product deviations by licensed manufacturers1
Activity by year
2023: 1
Where
North Carolina 1
Often inspects with
Is Xiaoxiao Pan coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2023-02-10 | 483 FUJIFILM Diosynth Biotechnologies U.S.A., IncFeb 10, 2023 · North Carolina | North Carolina | 3 |
About this profile
What does Xiaoxiao Pan inspect?
Xiaoxiao Pan appears on 1 document on file covering 1 site, mostly in North Carolina.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.22 and 21 CFR 600.14.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Xiaoxiao Pan is dated Feb 10, 2023.